When you address a letter and send it in the mail, you can be fairly confident it will reach the right place and nowhere else. The same can’t be said for delivering drugs in the body. Even if a ...

Biologic drugs are well established treatments for a wide range of disorders, and many of these medicines have become blockbuster products. But currently available biologics still have limitations, ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice newsletter. Flagship Pioneering has a knack for peering into the future.

Flagship Pioneering has revealed yet another pharmaceutical start-up—Ampersand Biomedicines. With $50 million in funding, the newly launched company aims to design programmable, tissue-selective ...

Antibodies and other protein therapeutics can treat a wide range of diseases, but they come with various challenges that have limited their reach. “They’re complex and expensive to make and complex to ...

Avak Kahvejian, Co-Founder and Chief Scientific Officer, to Present on "Programmable Medicines 2.0 with Endless RNA" SOMERVILLE, Mass., March 14, 2023 /PRNewswire/ -- Laronde, the company pioneering ...